Citadel Advisors’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.6K | Buy |
26,617
+2,350
| +10% | +$4.11K | ﹤0.01% | 5481 |
|
|
2025
Q1 | $43.2K | Buy |
24,267
+12,414
| +105% | +$22.1K | ﹤0.01% | 5405 |
|
|
2024
Q4 | $21.9K | Sell |
11,853
-9,414
| -44% | -$17.4K | ﹤0.01% | 5633 |
|
|
2024
Q3 | $48.7K | Sell |
21,267
-2,260
| -10% | -$5.18K | ﹤0.01% | 5126 |
|
|
2024
Q2 | $45.6K | Buy |
+23,527
| New | +$45.6K | ﹤0.01% | 5205 |
|
|
2023
Q3 | – | Sell |
-13,281
| Closed | -$41.7K | – | 6170 |
|
|
2023
Q2 | $41.7K | Buy |
+13,281
| New | +$41.7K | ﹤0.01% | 5051 |
|
|
2021
Q2 | – | Sell |
-25,250
| Closed | -$109K | – | 6722 |
|
|
2021
Q1 | $109K | Buy |
+25,250
| New | +$109K | ﹤0.01% | 5811 |
|